EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
tUEsdAy 25 JUnE <strong>2013</strong> - POSTERS MORNING<br />
08:30 - 12:30 Moderated Posters Moderated Poster<br />
Hot topics in genetics and anticoagulation<br />
Chairpersons: C. Wolpert (ludwigsburg, dE); s. tzeis (Maroussi, GR)<br />
Moderated Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and<br />
be on display from 08:30 until 12:30. The presenter should be present throughout the c<strong>of</strong>fee break<br />
(10:00 - 11:00) in order to discuss the poster.<br />
The following abstracts were chosen for their outstanding quality and will be discussed during the<br />
Moderated Poster session animated by two Chairpersons between 10:00 - 11:00. Each presenter will<br />
have 5 minutes to present and discuss their research in front <strong>of</strong> the audience and the chairpersons.<br />
family cluster as risk factor for catecholaminergic polymorphic ventricular tachycardia P918<br />
P.M. Ruiz Hernandez, F. Wanguemert, P. Berne, O. Campuzano, J. Brugada, R. Brugada<br />
(Las Palmas de Gran Canaria, Barcelona and Girona, ES)<br />
Clinical and genetic markers in stratification risk <strong>of</strong> sudden cardiac death in<br />
hypertrophic cardiomyopathy P919<br />
Y.N. Belenkov, E.V. Privalova, V.Y. Kaplunova, N.V. Khabarova, G.A. Shakaryants<br />
(Moscow, RU)<br />
Genetic variation in two chromosomal regions associated with AF influences local<br />
gene expression P920<br />
R.I.R. Martin, E. Glen, D.H. Hall, W.A. Owens, M. Santibanez-Koref, B.D. Keavney<br />
(Newcastle upon Tyne, GB)<br />
novel arrhythmia-related mutations in Croatian arrhythmia patients P921<br />
M. Dembic, S. Brusich, P.L. Hedley, Z. Cubranic, A.L. Carlsen, T.T. Pham, L. Zaputovic,<br />
M. Christiansen (Copenhagen, DK; Rijeka, HR)<br />
determination <strong>of</strong> polymorphism <strong>of</strong> a gene <strong>of</strong> alpha2betta adrenoreceptors at<br />
patients with atrioventricular block P922<br />
A. Chernova, S.Y.U. Nikulina (Krasnoyarsk, RU)<br />
did warfarin and antiplatelet reduce the incidence <strong>of</strong> dementia in patients with atrial<br />
fibrillation: a nationwide cohort study P923<br />
M.-T. Liao, L.Y. Lin, J.L. Lin (Hsinchu and Taipei, TW)<br />
Predictors <strong>of</strong> left atrium appendage clot detection despite on-target warfarin<br />
prevention for atrial fibrillation P924<br />
F. Zoppo, G. Brandolino, A. Berton, N. Frigato, M. Michieletto, A. Zanocco, F. Zerbo,<br />
E. Bacchiega, A. Lupo, E. Bertaglia (Mirano and Padua, IT)<br />
Are the CHADS2 and the CHADS2 VASc2 risk scores the same? Result from an<br />
atrial fibrillation registry in Argentine 925 (W)<br />
D. Di Toro, C.L.H. Hadid Claudio, S.G. Gallino Sebastian, C.D.L. Labadet Carlos<br />
(Ciudad Autonoma d3 Buenos Aires, AR)<br />
Validation <strong>of</strong> CHA2ds2-VAsc and HAs-blEd scores in Japanese patients with<br />
non-valvular atrial fibrillation: An analysis <strong>of</strong> J-RHYTHM Registry P926<br />
K. Okumura, H. Inoue, H. Atarashi, T. Yamashita, H. Tomita, H. Origasa<br />
(Hirosaki, Toyama, Tamanagayama and Tokyo, JP)<br />
Dose modification <strong>of</strong> rivaroxaban may reduce clinical benefits in patients with atrial<br />
fibrillation and moderate renal insufficiency compared with warfarin: a meta-analysis P927<br />
R. Sakurai (Tokyo, JP)<br />
137<br />
tuesday<br />
posters
Change language